NutriBand (NTRB) Total Debt Growth (3y) (2019 - 2026)
NutriBand (NTRB) Total Debt Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
NutriBand |
39.29 Mn |
34.71 Mn |
196,801.00 |
-32.14% |
| Date | Value |
|---|
| Apr 30, 2026 |
-32.14% |
| Jan 31, 2026 |
-29.07% |
| Oct 31, 2025 |
-26.67% |
| Jul 31, 2025 |
-25.80% |
| Apr 30, 2025 |
-23.10% |
| Jan 31, 2025 |
-16.82% |
| Oct 31, 2024 |
-15.23% |
| Jul 31, 2024 |
-13.84% |
| Apr 30, 2024 |
-12.60% |
| Jan 31, 2024 |
-18.97% |
| Oct 31, 2023 |
-20.35% |
| Jul 31, 2023 |
37.31% |
| Jan 31, 2023 |
14.19% |
| Oct 31, 2022 |
-39.60% |
| Jan 31, 2022 |
36.23% |
| Oct 31, 2021 |
37.77% |
| Jul 31, 2021 |
39.28% |
| Apr 30, 2021 |
39.74% |
| Jan 31, 2021 |
72.51% |
| Oct 31, 2020 |
116.03% |
